Freedom of Information request on if vaccine producers you have permitted thus far: 1) AstraZeneva 2) Pfizer 3) Moderna 4) Novavax 5) Janssen, use fetal bovine serum (Fbs) in making coronavirus vaccines? (FOI 22/547)
Published 1 June 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-21-march-2022/freedom-of-information-request-on-if-vaccine-producers-you-have-permitted-thus-far-1-astrazeneva-2-pfizer-3-moderna-4-novavax-5-janssen-use-fet
FOI 22/547
24th March 2022
Dear
Thank you for your email of 12 March where you have asked “ If vaccine producers you have permitted thus far: 1) AstraZeneva 2) Pfizer 3) Moderna 4) Novavax 5) Janssen, use fetal bovine serum (Fbs) in making coronavirus vaccines?”
Please note that foetal bovine serum (FBS) is not used during the commercial batch manufacture for any of the authorised Covid vaccines.
If you have a query about the information provided, please reply to this email.
Please remember to quote the reference number above in any future communications.
If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:
Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Yours sincerely
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000